Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02177825
Title Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Justine's Hospital
Indications
Therapies
Age Groups: child
Covered Countries CAN


No variant requirements are available.